Keratosis pilaris‐like eruption secondary to nilotinib in a child

Nilotinib is a new multitargeted tyrosine kinase inhibitor, which is used to treat chronic myelogenous leukemia when intolerance or recurrence to imatinib occurs. We report the case of a 14‐year‐old patient being treated with nilotinib who developed a keratosis pilaris‐like eruption. This cutaneous...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric dermatology 2020-09, Vol.37 (5), p.968-969
Hauptverfasser:	Oro‐Ayude, Marcos, Feito, Marta, Quintana‐Castanedo, Lucía, Beato‐Merino, Maria Jose, De Lucas, Raúl
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormalities, Multiple Adolescent Antineoplastic Agents BCR‐ABL‐positive Case reports chronic Chronic myeloid leukemia Darier Disease Enzyme inhibitors Eyebrows - abnormalities Fusion Proteins, bcr-abl Humans Imatinib Inhibitor drugs Intolerance Keratosis Leukemia myelogenous Myeloid leukemia Pediatrics protein kinase inhibitors Protein Kinase Inhibitors - adverse effects Protein-tyrosine kinase Pyrimidines - adverse effects Side effects Skin diseases Skin eruptions Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!